FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

329165006: Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3500943011 Hydroxyapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042410014 Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042411013 Durapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite-containing product false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Mineral supplement (substance) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Nutrient supplementation false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has manufactured dose form Tablet false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Genitourinary agent false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Durapatite (substance) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Nutritional supplement (substance) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Hydroxyapatite false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has active ingredient Hydroxyapatite false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has basis of strength substance (attribute) Hydroxyapatite false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has presentation strength numerator value 830 false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has precise active ingredient Hydroxyapatite false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite-containing product in oral dose form false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Count of base of active ingredient 1 false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Calcium phosphate only product in oral dose form false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite only product false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has basis of strength substance (attribute) Durapatite (substance) true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has precise active ingredient Durapatite (substance) true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite only product in oral dose form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start